Letter to the Editor

Bone Marrow Transplantation advance online publication 14 July 2008; doi: 10.1038/bmt.2008.200

Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT (Allo-HSCT) in the first CR

H Tamai1, H Yamaguchi1, S Takahashi2, A Tojo2, H Hamaguchi3, T Kobayashi4, H Akiyama4, H Sakamaki4, H Okumura5, Si Nakao5, A Arai6, O Miura6, K Tajika1, K Inokuchi1 and K Dan1

  1. 1Department of Hematology, Nippon Medical School, Tokyo, Japan
  2. 2Department of Hematology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
  3. 3Department of Hematology, Musashino Red Cross Hospital, Tokyo, Japan
  4. 4Department of Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
  5. 5Department of Hematology, Kanazawa University, Ishikawa, Japan
  6. 6Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan

Correspondence: H Tamai, E-mail: s6056@nms.ac.jp

Extra navigation

.

naturejobs

  • Chair

    • Cardiff University
    • Cardiff United Kingdom
  • Clinical Study Manager

    • Quintiles Technologies (India) Pvt. Ltd
    • Bangalore, Karnataka 560001 India

natureproducts


ADVERTISEMENT